Patents by Inventor Myra Christine Urness-Rusten

Myra Christine Urness-Rusten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11103582
    Abstract: Materials and methods for treating a patient to express a therapeutic agent comprising administering a Kupffer cell-suppressing substance in combination with a vehicle for introducing, into the patient, an exogenous nucleic acid comprising a sequence for expression of the agent.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: August 31, 2021
    Assignee: IMMUSOFT CORPORATION
    Inventors: R. Scott McIvor, Perry B. Hackett, Jason Bell, Myra Christine Urness-Rusten, Elena Aronovich, David W. Hunter
  • Publication number: 20180185487
    Abstract: Materials and methods for treating a patient to express a therapeutic agent comprising administering a Kupffer cell-suppressing substance in combination with a vehicle for introducing, into the patient, an exogenous nucleic acid comprising a sequence for expression of the agent.
    Type: Application
    Filed: January 5, 2018
    Publication date: July 5, 2018
    Inventors: R. Scott MCIVOR, Perry B. HACKETT, Jason BELL, Myra Christine URNESS-RUSTEN, Elena ARONOVICH, David W. HUNTER
  • Publication number: 20140141065
    Abstract: Materials and methods for treating a patient to express a therapeutic agent comprising administering a Kupffer cell-suppressing substance in combination with a vehicle for introducing, into the patient, an exogenous nucleic acid comprising a sequence for expression of the agent.
    Type: Application
    Filed: November 19, 2013
    Publication date: May 22, 2014
    Inventors: R. Scott McIvor, Perry B. Hackett, Jason Bell, Myra Christine Urness-Rusten, Elena Aronovich, David W. Hunter